Do you want to read an article? Please log in or register.
Potential of Nintedanib in Treatment of Progressive Fibrosing Interstitial Lung Diseases
Interstitial Lung DiseasePulmonary Fibrosis
RECOMMENDED
Related content
RECOMMENDED
Interstitial Lung DiseasePulmonary Fibrosis
Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
Lancet Respir Med.
Wells AU, Flaherty KR, Brown KK, Inoue Y, Devaraj A, Richeldi L, Moua T, Crestani B, Wuyts WA, Stowasser S, Quaresma M, Goeldner RG, Schlenker-Herceg R, Kolb M, INBUILD trial investigators.
doi: 10.1016/S2213-2600(20)30036-9.
RECOMMENDED
Interstitial Lung DiseasePulmonary Fibrosis
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
N Engl J Med.
Flaherty KR, Wells AU, Cottin V, Devaraj A, Walsh SLF, Inoue Y, Richeldi L, Kolb M, Tetzlaff K, Stowasser S, Coeck C, Clerisme-Beaty E, Rosenstock B, Quaresma M, Haeufel T, Goeldner RG, Schlenker-Herceg R, Brown KK, INBUILD Trial Investigators.
doi: 10.1056/NEJMoa1908681.
RECOMMENDED
Interstitial Lung Disease
The psychometric properties of the King's Brief Interstitial Lung Disease questionnaire and thresholds for meaningful treatment response in patients with progressive fibrosing interstitial lung diseases
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Eur Respir J
Birring SS, Bushnell DM, Baldwin M, Mueller H, Male N, Rohr KB, Inoue Y
doi: 10.1183/13993003.01790-2021
RECOMMENDED
Interstitial Lung Disease
Diagnostic and Prognostic Biomarkers for Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
doi: 10.1016/j.chest.2020.03.037.
RECOMMENDED
Interstitial Lung DiseasePulmonary Fibrosis
The natural history of progressive fibrosing interstitial lung diseases
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
★ 2
Recommended by
Dr Martin Frey, Faculty Member
doi: 10.1183/13993003.00085-2020.
RECOMMENDED
Interstitial Lung Disease
Efficacy and safety of nintedanib in Japanese patients with progressive fibrosing interstitial lung diseases: Subgroup analysis of the randomised, double-blind, placebo-controlled, phase 3 INBUILD trial
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Respir Med
Inoue Y, Suda T, Kitamura H, Okamoto M, Azuma A, Inase N, Kuwana M, Makino S, Nishioka Y, Ogura T, Takizawa A, Ugai H, Stowasser S, Schlenker-Herceg R, Takeuchi T
doi: 10.1016/j.rmed.2021.106574
RECOMMENDED
EmphysemaInterstitial Lung DiseasePulmonary Fibrosis
Progressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS® study)
Eur Respir J.
Nasser M, Larrieu S, Si-Mohamed S, Ahmad K, Boussel L, Brevet M, Chalabreysse L, Fabre C, Marque S, Revel D, Thivolet-Bejui F, Traclet J, Zeghmar S, Maucort-Boulch D, Cottin V
doi: 10.1183/13993003.02718-2020.
RECOMMENDED
Interstitial Lung DiseasePulmonary Fibrosis
Progression of fibrosing interstitial lung disease
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Res.
Wong AW, Ryerson CJ, Guler SA
doi: 10.1186/s12931-020-1296-3.
RECOMMENDED
Interstitial Lung DiseasePulmonary Fibrosis
Progressive fibrosing interstitial lung disease: treatable traits and therapeutic strategies
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Curr Opin Pulm Med.
Wongkarnjana A, Scallan C, Kolb MRJ
doi: 10.1097/MCP.0000000000000712.